Drug Safety

HSA Seizes Over $1.1M in Vaporisers

The Health Sciences Authority (HSA) seized over $1.1 million worth of vaporisers in an operation on February 24, 2026. New penalties under the Tobacco and Vaporisers Control Act (TVCA) will take effect from May 1, 2026, targeting importers, suppliers, and premises owners.

NY Health Urges Colorectal Cancer Screening for Adults 45+

The New York State Department of Health is urging adults aged 45 and older to get screened for colorectal cancer, as it is now a leading cause of cancer death for those under 50. The department highlights that screening can prevent or detect the cancer early, and aims to improve current screening rates across the state.

DEA Announces 10,744 Arrests in DC Safety Initiative

The Drug Enforcement Administration (DEA) announced 10,744 arrests as part of an initiative to enhance safety in Washington D.C. The operation involved collaboration between local and federal law enforcement agencies, with the goal of removing illicit substances from communities.

FDA Drug Shortage Update

The FDA has updated its list of current and resolved drug shortages. The notice indicates 56 drugs are currently in shortage, 45 have been resolved, and 11 have been discontinued. This update provides a snapshot of the ongoing drug supply situation.

FDA Report on Drug Shortage Prevention Efforts

The FDA has released its annual report to Congress detailing efforts in calendar year 2024 to prevent and mitigate drug shortages. The report highlights successful interventions that prevented 283 potential shortages, with only 15 new shortages identified.

FDA Extends Drug Use Dates Due to Shortages

The FDA has extended the use dates for specific lots of certain drugs to help alleviate drug shortages. This guidance allows providers and patients to use these lots beyond their labeled expiration dates, based on manufacturer stability data. The agency is not requiring relabeling but expects replacement and disposal when new product becomes available.

Class 2 Medicines Recall: Curaleaf Oil

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 Medicines Recall for three batches of Curaleaf Oil due to low THC content. Healthcare professionals are instructed to stop supplying the affected batches immediately.

Class 3 Medicines Recall: Bayer Plc, Various Products

Bayer Plc is recalling specific batches of Gastrografin, Urografin 150 Solution, and Urografin 150 Injection due to an impurity exceeding acceptable limits. This recall is a precautionary measure at the pharmacy and wholesaler level.

Field Safety Notices Issued March 2-6, 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a list of Field Safety Notices (FSNs) issued between March 2 and March 6, 2026. These notices detail safety concerns and required actions for specific medical devices, including those from ArjoHuntleigh, BD, Cook, Löwenstein, and OXOID.

Ford Recall 2026097: Rear Driveshaft Weld Issue

Transport Canada has issued recall 2026097 for Ford vehicles due to a potential issue with the rear driveshaft weld. This defect could lead to driveshaft separation and a loss of power, increasing the risk of a crash. Ford will notify owners to inspect and replace the affected component.